Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanoma.
Apparent diffusion coefficient
Diffusion magnetic resonance imaging
Melanoma
Metastasis
Whole-body imaging
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
29
03
2022
accepted:
04
08
2022
revised:
12
07
2022
pubmed:
29
9
2022
medline:
3
2
2023
entrez:
28
9
2022
Statut:
ppublish
Résumé
To establish optimised diffusion weightings ('b-values') for acquisition of whole-body diffusion-weighted MRI (WB-DWI) for estimation of the apparent diffusion coefficient (ADC) in patients with metastatic melanoma (MM). Existing recommendations for WB-DWI have not been optimised for the tumour properties in MM; therefore, evaluation of acquisition parameters is essential before embarking on larger studies. Retrospective clinical data and phantom experiments were used. Clinical data comprised 125 lesions from 14 examinations in 11 patients with multifocal MM, imaged before and/or after treatment with immunotherapy at a single institution. ADC estimates from these data were applied to a model to estimate the optimum b-value. A large non-diffusing phantom was used to assess eddy current-induced geometric distortion. Considering all tumour sites from pre- and post-treatment examinations together, metastases exhibited a large range of mean ADC values, [0.67-1.49] × 10 Theoretical optimisation gave an optimum b • Theoretical optimisation gave an optimum high b-value of 1100 (10th-90th percentile: 740-1790) s/mm
Identifiants
pubmed: 36169688
doi: 10.1007/s00330-022-09088-5
pii: 10.1007/s00330-022-09088-5
pmc: PMC9889461
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
863-871Subventions
Organisme : Cancer Research UK
ID : C1060/A10334, C1060/A16464
Pays : United Kingdom
Informations de copyright
© 2022. The Author(s).
Références
Padhani AR, Lecouvet FE, Tunariu N et al (2017) METastasis Reporting and Data System for Prostate Cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer. Eur Urol 71:81–92
doi: 10.1016/j.eururo.2016.05.033
Messiou C, Hillengass J, Delorme S et al (2019) Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS). Radiology 291:5–13
doi: 10.1148/radiol.2019181949
Taylor SA, Mallett S, Beare S et al (2019) Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial. Lancet Gastroenterol Hepatol 4:529–537
doi: 10.1016/S2468-1253(19)30056-1
Taylor SA, Mallett S, Ball S et al (2019) Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial. Lancet Respir Med 7:523–532
doi: 10.1016/S2213-2600(19)30090-6
Hausmann D, Jochum S, Utikal J et al (2011) Comparison of the diagnostic accuracy of whole-body MRI and whole-body CT in stage III/IV malignant melanoma. JDDG - J Ger Soc Dermatology 9:212–221
Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538–e548
doi: 10.1016/S1470-2045(14)70442-5
NICE Recommendations | Myeloma: diagnosis and management | Guidance. https://www.nice.org.uk/guidance/ng35 . Accessed 1 Apr 2021
Trabulsi EJ, Rumble RB, Jadvar H et al (2020) Optimum imaging strategies for advanced prostate cancer: ASCO guideline. J Clin Oncol 38:1963–1996
doi: 10.1200/JCO.19.02757
Barnes A, Alonzi R, Blackledge M et al (2018) UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer. Br J Radiol 91:20170577
doi: 10.1259/bjr.20170577
Consul N, Amini B, Ibarra-Rovira JJ et al (2021) Li-Fraumeni syndrome and whole-body MRI screening: screening guidelines, imaging features, and impact on patient management. AJR Am J Roentgenol 216:252–263
Petralia G, Padhani AR, Pricolo P et al (2019) Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses. Radiol Med 124:218–233
NICE Recommendations| Melanoma: assessment and management. https://www.nice.org.uk/guidance/ng14/chapter/1-Recommendations#staging-investigations-2 . Accessed 2 Dec 2021
Wolchok JD, Hoos A, O’Day S et al (2009) Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin Cancer Res 15:7412–7420
doi: 10.1158/1078-0432.CCR-09-1624
Larkin J, Chiarion-Sileni V, Gonzalez R et al (2019) Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 381:1535–1546
doi: 10.1056/NEJMoa1910836
O’Reilly A, Hughes P, Mann J et al (2020) An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors. Support Care Cancer 28:561–570
doi: 10.1007/s00520-019-04818-w
Lupo JM (2020) Diffusion MRI as an early marker of response to immune checkpoint inhibitors. Neuro Oncol 22:1557–1558
doi: 10.1093/neuonc/noaa224
Virtanen P, Gommers R, Oliphant TE et al (2020) SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods 17:261–272
doi: 10.1038/s41592-019-0686-2
Bito Y, Hirata S, Yamamoto E (1995) Optimum gradient factors for apparent diffusion coefficient measurements. Proc Intl Soc Mag Reson Med 913
Koh DM, Blackledge M, Padhani AR et al (2012) Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. AJR Am J Roentgenol 199:252–262
Haselgrove JC, Moore JR (1996) Correction for distortion of echo-planar images used to calculate the apparent diffusion coefficient. Magn Reson Med 36:960–964
doi: 10.1002/mrm.1910360620
Winfield JM, Collins DJ, Priest AN et al (2016) A framework for optimization of diffusion-weighted MRI protocols for large field-of-view abdominal-pelvic imaging in multicenter studies. Med Phys 43:95–110
doi: 10.1118/1.4937789
Messiou C, Collins DJ, Morgan VA, Desouza NM (2011) Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility. Eur Radiol 21:1713–1718
doi: 10.1007/s00330-011-2116-4
Horger M, Weisel K, Horger W et al (2011) Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: Preliminary results. AJR Am J Roentgenol 196:W790–W795
Lacognata C, Crimì F, Guolo A et al (2017) Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma. Clin Radiol 72:850–857
doi: 10.1016/j.crad.2017.05.004
Messiou C, Collins DJ, Giles S et al (2011) Assessing response in bone metastases in prostate cancer with diffusion weighted MRI. Eur Radiol 21:2169–2177
doi: 10.1007/s00330-011-2173-8
Güllmar D, Haueisen J, Reichenbach JR (2005) Analysis of b-value calculations in diffusion weighted and diffusion tensor imaging. Concepts Magn Reson Part A Bridg Educ Res 25:53–66
Saritas EU, Lee JH, Nishimura DG (2011) SNR dependence of optimal parameters for apparent diffusion coefficient measurements. IEEE Trans Med Imaging 30:424–437
doi: 10.1109/TMI.2010.2084583
Gauvain KM, Garbow JR, Song SK et al (2005) MRI detection of early bone metastases in B16 mouse melanoma models. Clin Exp Metastasis 22:403–411
doi: 10.1007/s10585-005-1264-9
Shukla-Dave A, Obuchowski NA, Chenevert TL et al (2019) Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials. J Magn Reson Imaging 49:e101–e121
doi: 10.1002/jmri.26518
Conturo TE, McKinstry RC, Akbudak E, Robinson BH (1996) Encoding of anisotropic diffusion with tetrahedral gradients: a general mathematical diffusion formalism and experimental results. Magn Reson Med 35:399–412
doi: 10.1002/mrm.1910350319